The cost of a life-saving drug in Canada is rising by 3,000 per cent. A national pharmacare plan could bring order to this chaotic world of Canadian drug prices.
Health Canada proposes to increase fees to the pharmaceutical industry for prescription drug approval. This will compromise drug safety and is a risk to the health of the Canadian public.
CVS, which operates nearly 10,000 pharmacies across the country, announced intentions to buy Aetna, the nation’s third-largest provider of health insurance. Here’s how consumers could be affected.
Specialty prescription drugs are responsible for countless medical miracles, but their high price tag is the main reason health care costs are out of control.
Canada is the only nation with a broad public health system lacking universal coverage for pharmaceuticals. Despite fears that pharmacare would be too costly, it could end up saving Canadians money.
The Orphan Drug Act was enacted 34 years ago to encourage the development of drugs for rare diseases. Drug companies were guaranteed seven years of exclusivity. Then the rush was on to run up prices.
Trump has vowed to use new bidding procedures to curb the soaring cost of new drugs. There’s a better solution, however, that doesn’t risk also curbing the development of lifesaving treatments.
The issue of crime committed under the influence of prescription drugs has received high profile media attention. So should we be worried about a new wave of prescription drug-induced crime?
Claire Meehan, University of Auckland, Waipapa Taumata Rau
Pharmaceutical companies can use prescription medication ads to mislead an unwitting public for the sake of profits. While Australia prohibits such ads, the laws don’t go far enough.